Aider is a “pair-programming” tool that can use various providers as the AI back end, including a locally running instance of ...

QuestDB comes with a very nice web console, but there's no CLI, so I wrote one (can't live without the terminal!). The REST API is very well defined: https://questdb ...

The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental ...

A large alligator nicknamed 'Godzilla' was caught on video dragging an enormous Burmese python through the water in the Florida Everglades.

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

Working It is the FT's workplace, future of work and leadership brand, led by Isabel Berwick. Sign up for Isabel's weekly Working It newsletter (here) which offers a sideways glance at the week's big ...

Bitcoin is back in the news. Hackers tried to scam Twitter users to send them money via Bitcoin using high-profile social media accounts. While we're all used to the idea of digital currency - ...

Subscribe to our weekly newsletter for the latest in industry news, expert insights, dedicated information security content and online events.

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Get the latest Replimune Group, Inc. (REPL) stock news and headlines to help you in your trading and investing decisions.

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...